Journal of Hepatocellular Carcinoma
Volume 11, 2024 - Issue
Open access
94
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma
Shadi Chamseddine1 Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
, Michael LaPelusa2 Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
, Lianchun Xiao3 Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
, Yehia I Mohamed1 Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
https://orcid.org/0000-0002-5192-3804View further author information
Sunyoung S Lee1 Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
, Zishuo Ian Hu1 Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
, Rikita I Hatia4 Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
https://orcid.org/0000-0003-2591-5963View further author information
Manal Hassan4 Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
, James C Yao1 Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
https://orcid.org/0000-0002-1875-3962View further author information
Dan G Duda5 Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USAView further author information
, Saumil Datar6 Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX, USAView further author information
, Hesham M Amin7 Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;8 MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USACorrespondence[email protected]
https://orcid.org/0000-0002-7973-6699View further author information
Ahmed O Kaseb1 Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
View further author information
show allView further author information
Pages 455-461
|
Received 13 Dec 2023, Accepted 28 Feb 2024, Published online: 04 Mar 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.